Contact Us

Leadership Team Scientific Advisory Board Board of Directors

Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing

Vector Science Videos White Papers

In the News Press Releases Conferences

Careers

Team ViroCell Leadership Team Scientific Advisory Board Board of Directors What we do Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing Innovative thinking Vector Science Videos White Papers

News In the News Press Releases Conferences Manufacturing dreams Careers Contact Us

Introducing ViroCell Biologics

In the NewsFlorence BuchananApril 28, 2021CDMO, clinical trials, viral vectors, cell and gene therapies

LinkedIn0 0 Likes

First UK-based clinical trial focused viral vector manufacturer announces launch

In the NewsFlorence BuchananApril 29, 2021CDMO, clinical trials, viral vectors, cell and gene therapies, ViroCell, Farzin Farzaneh, Truell Conservation Foundation, John Hadden II, gene therapy, cell therapy, CGT, UK CDMO, UR ALL news, vector design, AAV vectors, lentivirus vectors

Introducing ViroCell Biologics. The UK’s first clinical trial focused viral vector manufacturer.

In the NewsFlorence BuchananApril 28, 2021CDMO, ViroCell, viral vector, viral vectors, AAV vectors, lentivirus vectors, gene therapy, cell therapy, CGT, Farzin Farzaneh, John W. Hadden II, Contract Pharma, UK CDMO, vector design

Team ViroCell is on the road

7-10 May – ISCT, International Society for Cell & Gene Therapy, New Orleans

13-17 May – ASGCT, New Orleans

2-4 Sept – Advanced Therapies Week Europe, Barcelona

23-26 Sept – CAR-TCR Summit US, Boston

If you’re looking for a lentiviral and retroviral vector CDMO, we’d love to connect

videos Newsroom Careers Contact Us Terms of Use Privacy Notice

London New York

©2025 ViroCell Biologics, Ltd. All rights reserved.